The relevance and potential roles of microphysiological systems in biology and medicine

Experimental Biology and Medicine

Volumn 239, Issue 9, 2014, Pages 1061-1072

  Wikswo, John P ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

drug discovery and development; drug safety and toxicity; drug organ interactions; environmental toxicology; induced pluripotent stem cells; microphysiological systems; Organs on chips; quantitative systems pharmacology; systems biology; tissue engineered organ constructs

Indexed keywords

ARTICLE; BIOARTIFICIAL ORGAN; BIOLOGY; CLINICAL MEDICINE; CLINICAL PHARMACOLOGY; DRUG DESIGN; DRUG SAFETY; EXPERIMENTAL MODEL; MEDICINE; MICROPHYSIOLOGICAL SYSTEM; NONHUMAN; SIMULATION; SYSTEMS BIOLOGY; TISSUE ENGINEERING; ADULT; BIOPROSTHESIS; DRUG DISCOVERY AND DEVELOPMENT; DRUG SAFETY AND TOXICITY; DRUG-ORGAN INTERACTIONS; EDITORIAL; ENVIRONMENTAL TOXICOLOGY; EQUIPMENT; FEMALE; HUMAN; MALE; METHODOLOGY; MICROPHYSIOLOGICAL SYSTEMS; ORGANS ON CHIPS; PLURIPOTENT STEM CELL; QUANTITATIVE SYSTEMS PHARMACOLOGY; TISSUE-ENGINEERED ORGAN CONSTRUCTS;

DRUG DISCOVERY AND DEVELOPMENT; DRUG SAFETY AND TOXICITY; DRUG-ORGAN INTERACTIONS; ENVIRONMENTAL TOXICOLOGY; INDUCED PLURIPOTENT STEM CELLS; MICROPHYSIOLOGICAL SYSTEMS; ORGANS ON CHIPS; QUANTITATIVE SYSTEMS PHARMACOLOGY; SYSTEMS BIOLOGY; TISSUE-ENGINEERED ORGAN CONSTRUCTS;

ADULT; BIOPROSTHESIS; FEMALE; HUMANS; MALE; TISSUE ENGINEERING;

EID: 84907014643     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214542068     Document Type: Article

References (88)

1. Martin HN.The direct influence of gradual variations of temperature upon the rate of beat of the dog's heart.Philos Trans R Soc London. 1883;174:663-88
2. Langendorff O.Untersuchungen am Überlebenden Säugethierherzen.Pflug Arch Eur J Phys. 1895;61:291-332
3. Avis FR.Investigations of liver and kidney. Design of a dual apparatus for research study.Sci Teacher. 1961;28:14-8
4. Neely JR,Liebermeister H,Battersby EJ,Morgan HE.Effect of pressure development on oxygen consumption by isolated rat heart.Am J Physiol. 1967;212:804-14
5. Neely JR,Liebermeister H,Morgan HE.Effect of pressure development on membrane transport of glucose in isolated rat heart.Am J Physiol. 1967;212:815-22
6. Zimmer HG.The isolated perfused heart and its pioneers.News Physiol Sci. 1998;13:203-10
7. Exton JHCrucible of science: the story of the Cori laboratory. Oxford: Oxford University Press; 2013
8. Gadamer HGTruth and method. 2nd ed. New York: Continuum, 2000.New York: Continuum; 2000:
9. Sorger PK, Allerheiligen SRB, Abernethy DR, Altman RB, Brouwer KLR, Califano A, D'Argenio DZ, Iyengar R, Jusko WJ, Lalonde R, Lauffenburger DA, Shoichet B, Stevens JL, Subramaniam S, Van der Graaf P, Vicini P. Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms, http://www.nigms.nih.gov/Training/Documents/SystemsPharmaWPSorger2011.pdf (accessed October 2011).
10. Huang S,Wikswo JReviews of physiology, biochemistry and pharmacology. 157th ed. Berlin, Heidelberg: Springer, 2007, pp. 81–104.Amara SGBamberg EGudermann THebert SCJahn RLederer WJLill RMiyajima AOffermanns S, ed. Berlin, Heidelberg: Springer; 2007:81-104.
11. Bissell MJ,Radisky D.Putting tumours in context.Nat Rev Cancer. 2001;1:46-54
12. Baker BM,Chen CS.Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues.J Cell Sci. 2012;125:3015-24
13. Kola I,Landis J.Can the pharmaceutical industry reduce attrition rates?.Nat Rev Drug Discov. 2004;3:711-5
14. Astashkina A,Mann B,Grainger DW.A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity.Pharmacol Ther. 2012;134:82-106
15. Miesenbock G.Optogenetic control of cells and circuits.Annu Rev Cell Dev Biol. 2011;27:731-58
16. Chung K,Wallace J,Kim SY,Kalyanasundaram S,Andalman AS,Davidson TJ,Mirzabekov JJ,Zalocusky KA,Mattis J,Denisin AK,Pak S,Bernstein H,Ramakrishnan C,Grosenick L,Gradinaru V,Deisseroth K.Structural and molecular interrogation of intact biological systems.Nature. 2013;497:332-7
17. LeDuc PR,Messner WC,Wikswo JP.How do control-based approaches enter into biology?.Annu Rev Biomed Eng. 2011;13:369-96
18. Wikswo J,Curtis EL,Eagleton ZE,Evans BC,Kole A,Hofmeister LH,Matloff WJ.Scaling and systems biology for integrating multiple organs-on-a-chip.Lab Chip. 2013;13:3496-511
19. Domansky K,Inman W,Serdy J,Dash A,Lim MHM,Griffith LG.Perfused multiwell plate for 3D liver tissue engineering.Lab Chip. 2010;10:51-8
20. Huh D,Leslie DC,Matthews BD,Fraser JP,Jurek S,Hamilton GA,Thorneloe KS,McAlexander MA,Ingber DE.A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice.Sci Transl Med. 2012;4:159ra147-159ra147
21. Kim HJ,Huh D,Hamilton G,Ingber DE.Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow.Lab Chip. 2012;12:2165-74
22. Huh D,Matthews BD,Mammoto A,Montoya-Zavala M,Hsin HY,Ingber DE.Reconstituting organ-level lung functions on a chip.Science. 2010;328:1662-8
23. Moraes C,Labuz JM,Leung BM,Inoue M,Chun TH,Takayama S.On being the right size: scaling effects in designing a human-on-a-chip.Integr Biol. 2013;5:1149-61
24. Imura Y,Sato K,Yoshimura E.Micro total bioassay system for ingested substances: assessment of intestinal absorption, hepatic metabolism, and bioactivity.Anal Chem. 2010;82:9983-8
25. Shuler ML,Esch MB.Body-on-a chip: using microfluidic systems to predict human responses to drugs.Pure Appl Chem. 2010;82:1635-45
26. Esch MB,King TL,Shuler ML.The role of body-on-a-chip devices in drug and toxicity studies.Annu Rev Biomed Eng. 2011;13:55-72
27. Sung JH,Esch MB,Prot JM,Long CJ,Smith A,Hickman JJ,Shuler ML.Microfabricated mammalian organ systems and their integration into models of whole animals and humans.Lab Chip. 2013;13:1201-12
28. Wu MH,Huang SB,Lee GB.Microfluidic cell culture systems for drug research.Lab Chip. 2010;10:939-56
29. van der Meer AD,van den Berg A.Organs-on-chips: breaking the in vitro impasse.Integr Biol. 2012;4:461-70
30. Moraes C,Mehta G,Lesher-Perez SC,Takayama S.Organs-on-a-chip: a focus on compartmentalized microdevices.Ann Biomed Eng. 2012;40:1211-27
31. Huh D,Torisawa YS,Hamilton GA,Kim HJ,Ingber DE.Microengineered physiological biomimicry: organs-on-chips.Lab Chip. 2012;12:2156-64
32. Ghaemmaghami AM,Hancock MJ,Harrington H,Kaji H,Khademhosseini A.Biomimetic tissues on a chip for drug discovery.Drug Discov Today. 2012;17:173-81
33. Beebe DJ,Ingber DE,den Toonder J.Organs on chips 2013.Lab Chip. 2013;13:3447-8
34. Selimovic S,Dokmeci MR,Khademhosseini A.Organs-on-a-chip for drug discovery.Curr Opin Pharmacol. 2013;13:829-33
35. Delamarche E,Tonna N,Lovchik RD,Bianco F,Matteoli M.Pharmacology on microfluidics: multimodal analysis for studying cell-cell interaction.Curr Opin Pharmacol. 2013;13:821-8
36. Integrated microphysiological systems for drug efficacy and toxicity testing in human health and disease (UH2/UH3), http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-11-022.html (accessed 22 November 2011).
37. Microphysiological systems, https://www.fbo.gov/index?s=opportunity&mode=form&id=956b160c42aaa386cf5762f12c21be9f&tab=core&_cview=0 (accessed 11 September 2011).
38. Advancing regulatory science through novel research and science-based technologies (U01), http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-10-006.html (accessed 24 February 2010).
39. Fabre K, Livingston C, Tagle DA. Organs-on-chips (microphysiological systems): tools to expedite efficacy and toxicity testing in human tissue. Exp Biol Med 2014;239:1073–7.
40. Slikker W Jr. Of human-on-a-chip and humans: considerations for creating and using microphysiological systems. Exp Biol Med 2014;239:1078–9.
41. Alexander PG, Gottardi R, Lin H, Lozito TP, Tuan RS. Three dimensional osteogenic and chondrogenic systems to model osteochondral physiology and degenerative joint diseases. Exp Biol Med 2014;239: 1080–95.
42. Pamies D, Hartung T, Hogberg HT. Biological and medical applications of a brain-on-chip. Exp Biol Med 2014;239:1096–108.
43. Hartman KG, Bortner JD Jr, Falk GW, Ginsberg GG, Jhala N, Yu J, Martín MG, Rustgi AK, Lynch JP. Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems. Exp Biol Med 2014;239:1108–23.
44. Foulke-Abel J, In J, Kovbasnjuk O, Zachos NC, Ettayebi K, Blutt SE, Hyser JM, Zeng X-L, Crawford SE, Broughman JR, Estes MK, Donowitz M. Human enteroids as an ex vivo model of host-pathogen interactions in the GI tract. Exp Biol Med 2014;239:1124–34.
45. Nichols JE, Niles JA, Vega SP, Argueta LB, Eastaway A, Cortiella J. Modeling the lung: design and development of tissue engineered macro- and micro-physiologic lung models for research use. Exp Biol Med 2014;239:1135–70.
46. Clark AM, Wheeler SE, Taylor DP, Pillai VC, Young CL, Prantil-Baun R, Nguyen T, Stolz DB, Borenstein JT, Lauffenburger DA, Venkataramanan R, Griffith LG, Wells A. A microphysiological system model of therapy for liver micrometastases. Exp Biol Med 2014;239:1170–79.
47. Bale SS, Vernetti L, Senutovitch N, Jindal R, Hegde M, Gough A, McCarty WJ, Bakan A, Bhushan A, Shun TY, Golberg I, DeBiasio R, Usta BO, Taylor DL, Yarmush ML. In vitro platforms for evaluating liver toxicity. Exp Biol Med 2014;239:1180–92.
48. Tourovskaia A, Fauver M, Kramer G, Simonson S, Neumann T. Tissue-engineered microenvironment systems for modeling human vasculature. Exp Biol Med 2014;239:1264–71.
49. Eddie SL, Kim JJ, Woodruff TK, Burdette JE. Microphysiological modeling of the reproductive tract: a fertile endeavor. Exp Biol Med 2014;239:1192–202.
50. Cheng CS, Davis BNJ, Maddan L, Bursac N, Truskey GA. Physiology and metabolism of tissue engineered skeletal muscle. Exp Biol Med 2014;239:1203–14.
51. Eungdamrong NJ, Higgins C, Guo Z, Lee W-H, Gillette B, Sia S, Christiano AM. Challenges and promises in modeling dermatologic disorders with bioengineered skin. Exp Biol Med 2014;239:1215–24.
52. Sung JH, Srinivasan B, Esch MB, McLamb WT, Bernabini C, Shuler ML, Hickman JJ. Using PBPK guided “body-on-a-chip” systems to predict mammalian response to drug and chemical exposure. Exp Biol Med 2014;239:1125–40.
53. Heylman C, Sobrino A, Shirure VS, Hughes CCW, George SC. A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening. Exp Biol Med 2014;239:1240–54.
54. Cimetta E, Vunjak-Novakovic G. Microscale technologies for regulating human stem cell differentiation. Exp Biol Med 2014;239:1255–63.
55. Esch MB,Sung JH,Shuler ML.Promises, challenges and future directions of µCCAs.J Biotechnol. 2010;148:64-9
56. Wikswo JP,Block FE,Cliffel DE,Goodwin CR,Marasco CC,Markov DA,McLean DL,McLean JA,McKenzie JR,Reiserer RS,Samson PC,Schaffer DK,Seale KT,Sherrod SD.Engineering challenges for instrumenting and controlling integrated organ-on-a-chip systems.IEEE Trans Biomed Eng. 2013;60:682-90
57. Young EWK.Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment.Integr Biol. 2013;5:1096-109
58. Wikswo JP,Prokop A,Baudenbacher F,Cliffel D,Csukas B,Velkovsky M.Engineering challenges of BioNEMS: the integration of microfluidics, and micro- and nanodevices, models, and external control for systems biology.IEE Proc Nanobiotechnol. 2006;153:81-101
59. Faley S,Seale K,Hughey J,Schaffer DK,VanCompernolle S,McKinney B,Baudenbacher F,Unutmaz D,Wikswo JP.Microfluidic platform for real-time signaling analysis of multiple single T cells in parallel.Lab Chip. 2008;8:1700-12
60. Boron WF,Boulpaep ELMedical physiology: a cellular and molecular approach. Philadelphia, PA: Elsevier Saunders; 2005:
61. Sung JH,Shuler ML.A micro cell culture analog (µCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs.Lab Chip. 2009;9:1385-94
62. Kimmel DW,Dole WP,Cliffel DE.Application of multianalyte microphysiometry to characterize macrophage metabolic responses to oxidized LDL and effects of an apoA-1 mimetic.Biochem Biophys Res Commun. 2013;431:181-5
63. Shinawi TF,Kimmel DW,Cliffel DE.Multianalyte microphysiometry reveals changes in cellular bioenergetics upon exposure to fluorescent dyes.Anal Chem. 2013;85:11677-80
64. Harry RS,Hiatt LA,Kimmel DW,Carney CK,Halfpenny KC,Cliffel DE,Wright DW.Metabolic impact of 4-Hydroxynonenal on macrophage-like RAW 264.7 function and activation.Chem Res Toxicol. 2012;25:1643-51
65. Hiatt LA,McKenzie JR,Deravi LF,Harry RS,Wright DW,Cliffel DE.A printed superoxide dismutase coated electrode for the study of macrophage oxidative burst.Biosens Bioelectron. 2012;33:128-33
66. Kimmel DW,LeBlanc G,Meschievitz ME,Cliffel DE.Electrochemical sensors and biosensors.Anal Chem. 2012;84:685-707
67. McKenzie JR,Palubinsky AM,Brown JE,McLaughlin B,Cliffel DE.Metabolic multianalyte microphysiometry reveals extracellular acidosis is an essential mediator of neuronal preconditioning.ACS Chem Neurosci. 2012;3:510-8
68. Snider RM,McKenzie JR,Kraft L,Kozlov E,Wikswo JP,Cliffel DE.The effects of cholera toxin on cellular energy metabolism.Toxins. 2010;2:632-48
69. Zeiger SLH,McKenzie JR,Stankowski JN,Martin JA,Cliffel DE,McLaughlin B.Neuron specific metabolic adaptations following multi-day exposures to oxygen glucose deprivation.BBA-Mol Basis Dis. 2010;1802:1095-104
70. Eklund SE,Thompson RG,Snider RM,Carney CK,Wright DW,Wikswo J,Cliffel DE.Metabolic discrimination of select list agents by monitoring cellular responses in a multianalyte microphysiometer.Sensors. 2009;9:2117-33
71. Enders JR,Marasco CC,Wikswo JP,Mclean JA.A dual-column solid phase extraction strategy for online collection and preparation of continuously flowing effluent streams for mass spectrometry.Anal Chem. 2012;84:8467-74
72. Shi M,Majumdar D,Gao Y,Brewer BM,Goodwin CR,McLean JA,Li D,Webb DJ.Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts.Lab Chip. 2013;13:3008-21
73. Gubala V,Harris LF,Ricco AJ,Tan MX,Williams DE.Point of care diagnostics: status and future.Anal Chem. 2012;84:487-515
74. Schleicher E.The clinical chemistry laboratory: current status, problems and diagnostic prospects.Anal Bioanal Chem. 2006;384:124-31
75. Zaninotto M,Plebani M.The “hospital central laboratory“: automation, integration and clinical usefulness.Clin Chem Lab Med. 2010;48:911-7
76. Hester RL,Iliescu R,Summers R,Coleman TG.Systems biology and integrative physiological modelling.J Physiol Lond. 2011;589:1053-60
77. Hester RL, Brown AJ, Husband L, Iliescu R, Pruett D, Summers R, Coleman TG. HumMod: a modeling environment for the simulation of integrative human physiology. Front Physiol 2011;2:Article 12.
78. Fisher RA.The arrangement of field experiments.J Min Agric G Br. 1926;33:503-13
79. Chemical and biological defense innovations and technologies, http://www.grants.gov/search/search.do?mode=VIEW&oppId=133833 (accessed 12 December 2011).
80. Organotypic Culture Models for Predictive Toxicology Center. Funding Opportunity Number: EPA-G2013-STAR-L1, http://www.epa.gov/ncer/rfa/2013/2013_star_ocm.html (accessed 23 January 2014).
81. Basketter DA, Clewell H, Kimber I, Rossi A, Blaauboer B, Burrier R, Daneshian M, Eskes C, Goldberg A, Hasiwa N, Hoffmann S, Jaworska J, Knudsen TB, Landsiedel R, Leist M, Locke P, Maxwell G, Mckim J, Mcvey EA, Ouedraogo G, Patlewicz G, Pelkonen O, Roggen E, Rovida C, Ruhdel I, Schwarz M, Schepky A, Schoeters G, Skinner N, Trentz K, Turner M, Vanparys P, Yager J, Zurlo J, Hartung T. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. ALTEX 2012;29:3–91.
82. Increasing the capacity to perform nano-safety assessment, http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/2509-nmp-29-2015.html (accessed 11 December 2013).
83. New approaches to improve predictive human safety testing, http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/2283-phc-33-2015.html (accessed 11 December 2013).
84. EU project the body-on-a-chip: a next generation drug testing device, http://www.insphero.com/technology-innovation/eu-project-the-body-on-a-chip (accessed 26 May 2014).
85. Avis FRAbout mice and man. An introduction to advanced biology. Portland, ME: J. Weston Walch; 1962:
86. Rosenblueth A,Wiener N.The role of models in science.Philos Sci. 1945;12:316-21
87. Markel H.Experiments and observations: how William Beaumont and Alexis St. Martin seized the moment of scientific progress.JAMA. 2009;302:804-6
88. Markel H.Factual error in: experiments and observations: how William Beaumont and Alexis St. Martin seized the moment of scientific progress (vol 302, pg 804, 2009).JAMA. 2009;302:1420-1420